Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

YIPF5 Inhibitors

YIPF5 inhibitors are a class of chemical compounds that specifically target and inhibit the function of YIPF5 (Yip1 domain family member 5), a protein that is integral to the regulation of intracellular membrane trafficking, particularly between the endoplasmic reticulum (ER) and the Golgi apparatus. YIPF5 is part of the YIP (Ypt-interacting protein) family, which plays a critical role in the transport and organization of vesicles within cells. This protein is involved in maintaining the structural integrity of the Golgi and facilitating the proper sorting and delivery of proteins and lipids between cellular organelles. Inhibiting YIPF5 disrupts its normal function in vesicle formation and trafficking, which can lead to a deeper understanding of how membrane-bound compartments communicate and coordinate within the cell.

The design of YIPF5 inhibitors typically involves targeting specific domains of the protein that are essential for its role in vesicular transport. These inhibitors may work by binding to the YIPF5 protein at its active sites, preventing it from interacting with other proteins involved in vesicle formation and cargo transport. The inhibitors likely engage YIPF5 through non-covalent interactions, such as hydrogen bonding, van der Waals forces, or hydrophobic interactions, ensuring a stable and specific blockade of its function. By inhibiting YIPF5, researchers can investigate the mechanisms through which it controls membrane trafficking, organelle morphology, and protein sorting. These inhibitors are valuable tools for studying the broader cellular processes influenced by YIPF5, including the maintenance of the Golgi apparatus and the coordination of ER-to-Golgi transport, providing insights into the fundamental aspects of cellular organization and transport.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Inhibits ADP-ribosylation factor (ARF), indirectly impacting YIPF5 by disrupting Golgi structure.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

Ionophore that disrupts Golgi function, indirectly affecting YIPF5-related processes.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Disrupts microtubule polymerization, potentially impacting YIPF5-mediated transport.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$145.00
$442.00
64
(4)

Inhibits actin polymerization, affecting cellular transport and indirectly YIPF5 function.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Inhibits N-linked glycosylation, potentially influencing YIPF5 in the ER-Golgi network.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Disrupts ER calcium storage, indirectly affecting YIPF5 through ER stress pathways.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$187.00
$670.00
11
(1)

Directly targets Golgi BFA resistance factor 1, indirectly affecting YIPF5.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, potentially affecting pathways linked to YIPF5.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, indirectly affecting YIPF5 through protein synthesis and autophagy pathways.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Lysosomotropic agent, indirectly affecting cellular trafficking pathways involving YIPF5.